A Study of Nasopharyngeal Carcinoma From Guangdong
NCT03003182 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 2000
Last updated 2017-06-15
Summary
This prospective cohort study aims to establish prognostic models, to discover toxicity associated predictors and to validate randomized trials in clinical practice.
Conditions
- Nasopharyngeal Cancer
Sponsors & Collaborators
-
Sun Yat-sen University
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-05-10
- Primary Completion
- 2019-05-31
- Completion
- 2021-05-31
Countries
- China
Study Locations
More Related Trials
-
TPF+CCRT vs.CCRT+PF in High Risk Nasopharyngeal Carcinoma
NCT03306121 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Reduced-dose Versus Standard Dose Radiotherapy for Nasopharyngeal Carcinomain
NCT05304468 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Reduced-dose Radiotherapy for Low-risk Stage III Patients With Nasopharyngeal Carcinoma
NCT03668730 ·Status: UNKNOWN ·Phase: PHASE2
-
Concurrent Chemoradiotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
NCT03047265 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Chemotherapy Combined With Radiotherapy vs Chemotherapy Alone for Distant Metastatic Nasopharyngeal Carcinoma
NCT02111460 ·Status: UNKNOWN ·Phase: PHASE3
-
Chemotherapy Plus Subsequent Loco-regional Radiotherapy Combined With Toripalimab in the De Novo Metastatic Nasopharyngeal Carcinoma
NCT04398056 ·Status: UNKNOWN ·Phase: PHASE2
-
Detecting Chemosensitivity and Predicting Treatmemt Efficacy With CTCs in mNPC
NCT04544969 ·Status: RECRUITING
-
Platinum Plus Low-dose Long-term Continuous Intravenous Infused 5-Fluorouracil in Metastatic Nasopharyngeal Carcinoma
NCT04472403 ·Status: UNKNOWN
-
Endoscopic Nasopharyngectomy for Newly Diagnosed Stage I Nasopharyngeal Carcinoma Patients
NCT03353467 ·Status: RECRUITING ·Phase: NA
-
A Multicenter Trial Comparing Multi-course Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma
NCT00705627 ·Status: UNKNOWN ·Phase: PHASE3
-
Induction Gemcitabine and Cisplatin in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
NCT01872962 ·Status: UNKNOWN ·Phase: PHASE3
-
Gemcitabine-based Induction Chemotherapy Combined With Concurrent Chemoradiotherapy in Locally Advanced Nasopharyngeal Carcinoma
NCT04522050 ·Status: UNKNOWN ·Phase: PHASE1
-
Two Cycles Versus Three Cyclle of CCRT for Low Risk Locoregionally Advanced Nasopharyngeal Carcinoma
NCT02871518 ·Status: UNKNOWN ·Phase: PHASE2
-
Reduced-target Resection After Induction Chemotherapy in Resectable Recurrent Nasopharyngeal Carcinoma
NCT05877872 ·Status: RECRUITING ·Phase: PHASE3
-
Nedaplatin Versus Cisplatin and Capecitabine Versus Fluorouracil in IC + CCRT for Locoregionally Advanced NPC
NCT03503136 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Surgery Plus Reduced Target Chemoradiotherapy vs Surgery Plus Reduced Dose Chemoradiotherapy for Newly Diagnosed Operable Nasopharyngeal Carcinoma.
NCT06529562 ·Status: RECRUITING ·Phase: NA
-
Programmed Death-1 (PD-1) Antibody Combined With Chemoradiotherapy in High-risk Recurrent Nasopharyngeal Carcinoma
NCT03930498 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Adjuvant Chemotherapy in Patients With Locoregionally Advanced Nasopharyngeal Carcinoma
NCT00677118 ·Status: UNKNOWN ·Phase: PHASE3
-
Platinum Plus Low-dose Long-term Continuous Intravenous Infused 5-Fluorouracil in Recurrent Nasopharyngeal Carcinoma
NCT04764149 ·Status: UNKNOWN
-
TPC vs PF as Induction Chemotherapy Combined With CCRT for Stage IVa-b Nasopharyngeal Carcinoma
NCT02940925 ·Status: COMPLETED ·Phase: PHASE3
-
Chemoradiotherapy Plus Anti-PD1 in Recurrent NPC: A Multicenter, Open-label, Randomised, Controlled, Phase III Trial
NCT05340491 ·Status: RECRUITING ·Phase: PHASE3
-
Concurrent Chemoradiotherapy With Nedaplatin Versus Cisplatin in Nasopharyngeal Carcinoma
NCT01540136 ·Status: COMPLETED ·Phase: PHASE3
-
GP Plus Adebrelimab Versus GP Neoadjuvant Chemotherapy for Nasopharyngeal Carcinoma
NCT06455410 ·Status: RECRUITING ·Phase: PHASE2
-
A Trial On 4 Cycles Of Neoadjuvant Chemotherapy Plus Concurrent Chemoradiation In N2-3 Nasopharyngeal Carcinoma
NCT02512315 ·Status: UNKNOWN ·Phase: PHASE3
-
Phase Ⅲ Trial of Adjuvant Chemotherapy in Patients With N2-3 Nasopharyngeal Carcinoma
NCT03321539 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3